Chile vs Iran: Share of newborns vaccinated against tuberculosis

Chile
99.0%
in 2024
Iran
99.0%
in 2024
Chile rank
1st
Iran rank
1st

Share of newborns vaccinated against tuberculosis over time

  • Chile
  • Iran
020406080100198020022024

How they compare

Chile currently reports 99.0% against 99.0% in Iran, a difference of 0.0%.

The two have swapped places 7 times across 45 shared years of data; in 1980 it was Chile ahead.

Chile ranks 1st and Iran ranks 1st of 166 countries.

Across the 5 decades both report, Chile averaged higher in 1 and Iran in 4.

Head to head by decade

Decade Chile Iran Difference Ahead
1980s 95.7% 40.7% 55.0% Chile
1990s 96.3% 96.4% 0.1% Iran
2000s 96.2% 98.0% 1.8% Iran
2010s 95.4% 99.0% 3.6% Iran
2020s 98.4% 98.8% 0.4% Iran

Averages of every year both report within each decade.

Frequently asked questions

Which has higher share of newborns vaccinated against tuberculosis, Chile or Iran?
Chile, at 99.0% against 99.0% in Iran as of 2024.
What is the difference in share of newborns vaccinated against tuberculosis between Chile and Iran?
0.0%, with Chile ahead.
How many years of comparable data are there for Chile and Iran?
45 years are reported by both, from 1980 to 2024.
How do Chile and Iran rank globally for share of newborns vaccinated against tuberculosis?
Chile ranks 1st and Iran ranks 1st of 166 countries.
Where does this data come from?
WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of newborns vaccinated against tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Share of newborns vaccinated against tuberculosis
Unit
%
Source
WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
166 places, 6,610 data points, 1980–2024
Last refreshed

Share of newborns who have had one dose of the tuberculosis (BCG) vaccine in a given year.